Analgesics

The reopened border between mainland China and Hong Kong in early 2023 had significant implications for the demand of analgesic remedies within the city, which rose considerably. This growth can be attributed to a shortage of analgesic remedies…

Despite a decline in the number of COVID-19 cases, demand for analgesics continued to grow in 2023. This was partly due to the revival of pre-pandemic behavioural patterns, including the cessation of mask wearing and social distancing, which meant…

The driving force behind the growth of analgesics in India is the Millennial population, which includes those born between 1980 and 1994. This demographic, consisting of 328 million people, significantly drives demand for analgesics. The key reason…

The topical analgesics/anaesthetic category is poised to record the fastest growth in volume and current value terms within analgesics in 2023, and looks set to show improved results in both respects as compared to 2022. These types of products…

Due to the high rates of vaccination amongst Singaporeans, systemic analgesics were purchased in high quantities in 2022 to fulfil the demand to self-medicate amidst post-vaccination symptoms and common cold symptoms from later variants of the…

Towards the end of the review period, demand for analgesics was supported by the widening of the consumer base for these products as the advantages of using analgesics to manage headaches and other moderate types of pain became better known among the…

Sales of analgesics in Japan have seen solid growth in current value terms in 2023 backed by increased opportunities for consumers to go out, the recovery in the number of inbound tourists, and a move away from the practice of wearing face masks on a…

The return of consumers to their busy-pandemic lifestyles had a positive impact on demand for analgesics in Malaysia in 2023. Within this, topical analgesics/anaesthetic remained the largest subcategory, as well as being the key driver of growth.…

Analgesics in Uzbekistan is still developing with growth opportunities in several subcategories. Current value sales remained in double-digits in 2023 continuing the trend seen throughout the review period. Analgesics tend to be purchased in…

Despite the overall waning impact of the pandemic in South Korea, simultaneous new outbreaks of COVID-19, influenza, and the common cold (referred to as a “tripledemic” in the country) are leading to a sharp increase in the number of consumers…

Analgesics is expected to register moderate constant value growth in 2023. In spite of continuing very high inflation, volume growth is also expected to be healthy, and is supported by continuing population growth. Price limits on analgesics is also…

In 2023, the COVID-19 pandemic has lost some of its disruptive potency; however, analgesic sales in Azerbaijan are ticking upwards in value terms (with the exception of adult aspirin). Value sales are being pushed by Azerbaijan's reliance on imports,…

Analgesics is projected to continue to post fast retail volume growth over 2023. The potential for even higher growth is restricted by many households retaining stocks of analgesics purchased during the Coronavirus (COVID-19) pandemic. One clear…

In the context of transforming the health system in Indonesia, one of the agendas currently being pursued by the Ministry of Health is to increase pharmaceutical resilience by increasing domestic production of the top 10 value medicines, which…

The pandemic boosted demand for analgesics in Vietnam, as consumers believed that it was necessary to store analgesics at home as a precautionary measure. Adult and paediatric acetaminophen performed particularly well in 2020 and 2021, as…

Even after seeing exceptional current value growth in 2022, it is anticipated that analgesics will continue to experience double-digit growth in 2023. This can primarily be attributed to the substantial increase in COVID-19 cases in China starting…